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Abstract 
Porcine reproductive and respiratory syndrome virus (PRRSV) infects mainly the porcine 
alveolar  macrophages  (PAMs)  and  causes  porcine  reproductive  and  respiratory  syn-
drome (PRRS). Previous studies have analyzed the global gene expression profiles of 
lung tissue in vivo and PAMs in vitro following infection with PRRSV, however, tran-
scriptome-wide  understanding  of  the  interaction  between  highly  pathogenic  PRRSV 
(HP-PRRSV) and PAMs in vivo has not yet been established. In this study, we employed 
Affymetrix microarrays to investigate the gene expression patterns of PAMs  isolated 
from Tongcheng piglets (a Chinese indigenous breed) after infection with HP-PRRSV. 
During the infection, Tongcheng piglets exhibited typical clinical signs, e.g. fever, asth-
ma,  coughing,  anorexia,  lethargy  and  convulsion,  but  displayed  mild  regional  lung 
damage at 5 and 7 dpi. Microarray analysis revealed that HP-PRRSV infection has af-
fected PAMs in expression of the important genes involved in cytoskeleton and exocyto-
sis organization, protein degradation and folding, intracellular calcium and zinc homeo-
stasis. Several potential antiviral strategies might be employed in PAMs, including up-
regulating IFN-induced genes and increasing intracellular zinc ion concentration. And 
inhibition  of  the  complement  system  likely  attenuated  the  lung  damage  during 
HP-PRRSV infection. Transcriptomic analysis of PAMs in vivo could lead to a better un-
derstanding of the HP-PRRSV-host interaction, and to the identification of novel antiviral 
therapies and genetic components of swine tolerance/susceptibility to HP-PRRS. 
Key words: microarray, HP-PRRSV-host interaction, infection, pulmonary alveolar macrophage, 
antiviral strategy 
Introduction 
Porcine reproductive and respiratory syndrome 
(PRRS), caused by PRRS virus (PRRSV) which belongs 
to the genus Arterivirus of the family Arteriviridae, is 
the  most  economically  significant  disease  effecting 
commercially bred pigs world-wide [1]. This disease 
is  characterized  by  anorexia,  increased  late-term 
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abortions, increased number of stillborn pigs, mum-
mified  fetuses,  weak  live-born  piglets,  increased 
pre-weaning mortality, and delayed return to estrus 
[2]. In vivo,  PRRSV productive infection occurs pre-
dominately in alveolar macrophages of the lung [3], 
followed  by  viremia  and  subsequent  interstitial 
pneumonia  within  3  days  [4].  It  was  hypothesized 
that  respiratory  pathology,  especially  lung  damage 
during PRRSV infection, results from an overproduc-
tion of pro-inflammatory cytokines in the lungs [5].  
Genome-wide transcriptional responses of lungs 
of Landrace×Yorkshire crossbred piglets to a classical 
North American type PRRSV strain infection was an-
alyzed by Solexa/Illumina’s Digital Gene Expression 
(DGE) System, which is a tag-based high-throughput 
transcriptome sequencing method [6]. This systematic 
analysis  of  the  pulmonary  gene  expression  profiles 
suggested  that  upregulation  expression  of 
pro-inflammatory  cytokines,  chemokines,  adhesion 
molecules  and  inflammatory  enzymes  and  inflam-
matory cells, antibodies, complement activation were 
likely to result in the development of inflammatory 
responses during PRRSV infection processes [6]. An-
other  high-throughput  deep  sequencing  was  per-
formed focusing on the pulmonary gene expression 
profiles  after  a  highly  pathogenic-PRRSV 
(HP-PRRSV) strain infection [7]. The system analysis 
of  the  pulmonary  gene  expression  provides  a  com-
prehensive basis for better understanding the patho-
genesis  of  HP-PRRSV  [7].  Because  PRRSV  infection 
occurs  predominately  in  porcine  alveolar  macro-
phages  (PAMs)  [3],  the  interaction  between  PRRSV 
and  PAMs  have  been  studied  systematically  by 
high-throughput  research  methods  in  vitro.  PAMs, 
lavaged  from  six  piglets,  were  challenged  with  the 
Lelystad PRRSV strain in vitro, and the gene expres-
sion of the PAMs was investigated using Affymetrix 
microarrays [8]. The result suggested that the expres-
sion of beta interferon 1 (IFN-β), but not of IFN-α, was 
strongly upregulated in the early stage of PRRSV in-
fection  [8].  Besides  microarray,  Serial  Analysis  of 
Gene  Expression  (SAGE)  was  also  employed  to  ex-
amine  the  global  expression  of  genes  in 
PRRSV-infected PAMs in vitro [9]. These studies have 
provided global gene expression profiles of lung tis-
sue in vivo and PAMs in vitro following infection with 
PRRSV; however, transcriptome-wide understanding 
of the interaction between PRRSV and PAMs in vivo 
has not yet been established. 
In 2006, an unparalleled large-scale outbreak of 
highly pathogenic PRRS (HP-PRRS) occured in many 
areas  of  China.  This  outbreak  affected  more  than  2 
millions pigs and produced approximately 0.4 million 
fatal cases [10]. In this study, laboratory infection was 
performed  in  Tongcheng  piglets  (a  Chinese  indige-
nous  breed  living  in  Tongcheng  county  of  Hubei 
province)  using  PRRSV  stain  WUH3  [11],  a  highly 
pathogenic PRRSV isolated in China during the pan-
demic period of HP-PRRS in 2006. We also employed 
Affymetrix  microarrays  to  investigate  the  gene  ex-
pression patterns of PAMs isolated from the piglets 
after infection. The current study aims at better un-
derstanding the interaction between HP-PRRSV and 
the host PAMs, which may lead to the identification of 
key  host  factors  for  tolerance/susceptibility  to  the 
virus  and  the  finding  of  novel  targets  for  antiviral 
therapies. 
Materials and methods 
Animals and experimental design 
All animal procedures were performed accord-
ing to protocols approved by the Biological Studies 
Animal Care and Use Committee of Hubei Province, 
China.  Piglets  used  in  this  study  were  free  from 
PRRSV,  pseudorabies  virus  (PRV)  and  porcine 
circovirus type 2 (PCV2) determined by ELISA test for 
serum  antibodies.  Twelve  5-week-old  Tongcheng 
boars  (a  Chinese  indigenous  breed)  were  obtained 
from three litters (four piglets per litter), and raised in 
pathogen-free facilities. To perform a paired experi-
ment,  individuals  within  a  full-sib  litter  were  sepa-
rated  into  two  groups:  one  infected  group  and  one 
control group with 6 piglets in each group. The in-
fected groups were challenged with PRRSV-WUH3 (3 
ml/15 kg, 10-5 TCID50/ml) by intramuscular inocula-
tion.  Slaughters  were  carried  out  at  0  day 
post-infection  (dpi)  for  uninfected  (control)  groups, 
and at 5 or 7 dpi for infected groups. Rectal tempera-
ture and clinical signs were recorded daily during the 
experiment. The serum samples for viremia detection 
were collected daily from all animals (one ml blood 
per sampling point). The PAMs for microarray analy-
sis  were  collected  by  bronchoalveolar  lavage  from 
three uninfected pigs and three infected pigs at 5 dpi.  
Gross and microscopic lung lesions 
Post-mortem  examinations  were  performed  on 
all pigs. Macroscopic lung lesions were given a sub-
jective  score  to  estimate  the  percentage  of  the  lung 
affected  by  pneumonia,  following  a  scoring  system 
described  previously  [12,  13].  For  histopathology 
analysis, samples of the apical segment of the lower 
lung  lobes  were  collected  and  fixed  in  4%  para-
formalclehyde  for  24  h.  Fixed  samples  were  dehy-
drated,  embedded  in  paraffin,  sectioned  into  4  μm 
and  stained  with  hematoxylin  and  eosin.  Sections 




Viral load determination 
For viremia detection, serum samples were col-
lected daily from all pigs. Total viral RNA was ex-
tracted  from  200  μl  serum  using  TRIzol  Reagent 
(Invitrogen,  Carlsbad,  CA).  cDNA  was  synthesized 
using  oligo(dT)15  primer,  M-MLV  Reverse  Tran-
scriptase  (Promega,  Madison,  WI)  in  50  μl  reaction 
mixture according to the manufacturer’s instructions. 
Absolute  quantitative-PCR  (Q-PCR)  was  performed 
using primers specific to the ORF7 of PRRSV (sense: 
5’-TCA GCT GTG CCA AAT GCT GG-3’; antisense: 
5’-AAA TGG GGC TTC TCC GGG TTT T-3’). For ab-
solute  quantification,  the  pET-18M  plasmid  of  the 
known copy number containing the ORF7 fragment 
generated standard curve. Viral copies per ml of the 
unknown samples were determined by linear extrap-
olation of the Ct value plotted against the standard 
curve [14].  
RNA extraction and microarray hybridization 
TRIzol  (Invitrogen)  was  used  for  RNA  extrac-
tions following the manufacturer’s instructions. RNA 
integrity and concentration were evaluated by dena-
turing formaldehyde gel electrophoresis and Agilent 
2100  Bioanalyzer.  The  RNA  samples  were  sent  to 
GeneTech  Biotechnology  Limited  Company  (Shang-
hai, China) for hybridization to the porcine Affymet-
rix GeneChip (Affymetrix, Santa Clara, CA). A total of 
6 microarray analyses were conducted using the pro-
cedure described previously [15]. 
Microarray data analysis 
The  raw  data  (Affymetrix  GeneChip  Scanner 
3000) was converted to gene signal files by MAS 5.0 
(Microarray Suite Version 5.0, Affymetrix). The data 
points  were  normalized  between  slides  using  the 
quantile normalization method used by Bolstad et al. 
[16]. The differentially expressed genes were selected 
using the SAM (Significance Analysis of Microarrays) 
package  (http://www-stat.stanford.edu/~tibs/ 
SAM/),  and  the  false  discovery  rate  (FDR)  values 
were  generated  using  permutations  of  the  repeated 
measurements  to  estimate  the  percentage  of  genes 
identified by chance. In the experiment, SAM settings 
were adjusted for a two class paired analysis, using 
one hundred permutations to calculate the differen-
tially expressed gene list. The fold-change of 1.5 and a 
false discovery rate of approximately 5% were set as a 
threshold. All data are MIAME compliant and have 
been deposited in NCBI’s Gene Expression Omnibus 
and  are  accessible  through  GEO  Series  accession 
number  GSE22782  (http://www.ncbi.nlm.nih.gov 
/geo/query/acc.cgi?acc=GSE22782).  Differential 
gene  expressions  were  performed  for  hierarchical 
cluster  (Ver.3.0)  and  TreeView  (Ver.1.60)  analyses 
[17].  The  functional  annotation  of  differentially  ex-
pressed  genes  was  performed  by  the  DAVID  (The 
Database for Annotation, Visualization and Integrat-
ed  Discovery)  gene  annotation  tool 
(http://david.abcc.ncifcrf.gov/)  [18],  as  well  as  by 
referring to a previous work [19]. 
Q-PCR  
The  RNA  samples  prepared  for  microarray 
analysis  were also  used for Q-PCR verification. Re-
verse  transcriptions  were  performed  using  M-MLV 
Reverse  Transcriptase  (Promega)  according  to  the 
manufacturer’s  instructions.  The  primers  were  de-
signed  with  the  Primer  Premier  5.0  program.  The 
RPL32 gene was used as the internal control [20]. The 
primer sequences, melting temperatures and product 
sizes are shown in Table 1. Q-PCR was performed on 
the LightCycler 480Ⅱ (Roche, Basel, Sweden) using 
SYBR  Green  Realtime  PCR  Master  Mix  (TOYOBO 
CO., LTD, Japan) as the readout. Data was analyzed 
by the 2-ΔΔCT method [21]. The data analysis procedure 
was performed as described previously [15]. 
Results 
Clinical and pathological features of 
HP-PRRSV-infected piglets 
After infection with PRRSV-WUH3, the piglets 
presented  typical  clinical  signs,  e.g.  fever,  asthma, 
coughing,  anorexia,  lethargy  and  convulsion.  The 
average rectal temperature rose to above 40.5 ºC at 2 
dpi and seemed to peak at 5 dpi. The two piglets sur-
viving  at  5  dpi  showed  a  slight  decrease  of  rectal 
temperature in the following two days (Figure 1A). To 
assess the replication and spread of HP-PRRSV, the 
viral copy number/ml in serum was determined by 
absolute real-time quantitative-PCR (Figure 1B). The 
level of viremia increased rapidly during the first two 
days post-infection, then increased slowly from 3 to 5 
dpi, and approached the plateau phase at 6 or 7 dpi.  
Pathologic examination was carried out on the 
animals.  Macroscopic  examination  detected  a  mild 
lung lesion at the apical segment of the lower lobes at 
5 and 7 dpi (Figure 1C). For estimating the severity of 
the pneumonia, gross lung lesion scores were made 
based  on  the  method  described  previously  [12,  13]. 
The low scores indicated a mild regional lung damage 
at 5 and 7 days after HP-PRRSV infection (Figure 1D). 
As compared with the uninfected group (Figure 1E), 
microscopic examination detected a certain extent of 
congestion as well as interstitial infiltration of leuko-





Table 1 Primers used for Q-PCR validation 
Gene  Primer sequence (5'-3')  Target size (bp)  Tm (℃)a 
C3  Forward: AAACTAAAGGAGGGGGGACACT 
Reverse: CTTGGCATACATCACCATCAGG 
133  60 
CCL2  Forward: AACTTGCCCTAAATACCCTCAGA 
Reverse: GGAAAGCAATGTGCCCAAGTC 
179  61 
DDIT3  Forward: ACGGCTCAAGCAGGAAATC 
Reverse: CACTGGTAAGAAGGTGGTTGGT 
173  58 
EMP1  Forward: CTCAGATGCGGGACAAGGA 
Reverse: AAGACCACGAGGGAGACGA 
156  58 
GLRX2  Forward: TACGGAAGCCAGTTTCAAGAC 
Reverse: CTTGGTGAAGCCTATGAGTGTC 
118  58 
TNF  Forward: CATCGCCGTCTCCTACCA 
Reverse: CCCAGATTCAGCAAAGTCCA 
199  58 
RPL32b  Forward: CGGAAGTTTCTGGTACACAATGTAA 
Reverse: TGGAAGAGACGTTGTGAGCAA 
94  58-61 
aThe annealing temperature represents the optimal temperature during quantitative PCR; 




Figure 1 Laboratory infection of Tongcheng piglets with HP-PRRSV. A: Rectal temperature of the piglets; B: Viral copy 
numbers per ml serum determined by absolute real-time quantitative PCR; C: Lung morphology of piglets slaughtered at 0, 
5 or 7 dpi; D: Gross lung lesion scores of the piglets. The scores of 0 to 100 denote the different severity of gross lung lesion, 
from intact to totally damaged; E and F: Paraffin sections of the apex of lung at 0 dpi (E) and 5 dpi (F), stained with he-





Transcriptome analysis of the virus-host cell 
interaction in vivo 
PAMs  samples  collected  from  three  infected 
piglets at 5 dpi and three uninfected piglets were an-
alyzed.  A  total  of  12,775  transcripts  (53%  of  all 
probesets)  were  expressed  in  infected  and 
non-infected  PAMs  (Supplementary  Table  1).  After 
quantile normalization, 321 genes were identified as 
differentially  expressed  (DE)  genes,  with  219  being 
upregulated and 102 being downregulated, under the 
threshold of fold change (FC) of 1.5 or greater and a 
false discovery rate (FDR) of approximately 5% (Fig-
ure 2A and Supplementary Table 2).  
Based on the Database for Annotation, Visuali-
zation and Integrated Discovery (DAVID), 166 of the 
DE genes were classified into 47 categories, many of 
which  shared  the  same  genes,  according  to  their 
functional correlation (Figure 2B and Supplementary 
Table 3). The majority of the genes related to the vi-
rus-host  cell  interaction  could  be  assigned  into  the 
categories including cell death and apoptosis related, 
response to wounding, response to unfolded protein, 
response to oxidative stress, response to virus, innate 
immune response, response to cytokine stimulus, and 
endoplasmic reticulum (ER) overload response. Other 
DE  genes  that  were  not  classified  by  DAVID  were 




Figure  2  Microarray  analysis  of  PAMs’  transcriptional  responses  to  HP-PRRSV  infection.  A:  Hierarchical  clustering 
analysis of gene expression profiles pre- and post-infection. Each column represents one piglet, and each horizontal line 
refers to a gene. Color legend is on the top-left of the figure. Red indicates genes with a greater expression relative to the 
geometrical means, green indicates genes with a lower expression relative to the geometrical means; B: Biological process 
Gene Ontology (GO) analysis of 166 differentially expressed genes. Many categories shared the same transcripts.  





Sensing the HP-PRRSV infection by PAMs 
In macrophages, PRRSV entry into the host cell 
is mediated by heparan sulphate proteoglycans and 
the receptor sialoadhesin. Upon a pH drop, PRRSV is 
uncoated and its genome is released from the endo-
somes into the cytoplasm, which allows virus replica-
tion  [22].  After  HP-PRRSV  infection  the  ATP6V1B2 
gene, which encodes a component of vacuolar ATPase 
(V-ATPase) that mediates acidification of endosomal 
organelles [23], was upregulated (Figure 3). SARM1, a 
negative  regulator  of  TRIF-dependent  Toll-like  re-
ceptor (TLR) signaling [24] and MAPK phosphoryla-
tion [25], was significantly downregulated (Figure 3). 
SBNO2, a potent inhibitor of NF-κB [26], and SOCS1 
which limits NF-κB signaling by decreasing p65 sta-
bility within the cell nucleus [27], were upregulated 
(Figure  3).  Upon  HP-PRRSV  infection,  IRF7  was 
found to be upregulated in PAMs at 5 dpi (Figure 3), 
however, no type-I IFN or IFN-γ induction was ob-
served. A number of IFN-induced genes (IFI6, IFI16, 
IFIH1,  IFIT2,  IFIT3,  IFITM3,  GBP1,  GBP2,  MX1, 
GZMB,  GZMH,  ISG15,  USP18,  RSAD2,  NMI)  were 
upregulated (Table 2). JAK-STAT pathway seemed to 
be positively (STAT1 and NMI) as well as negatively 
(SOCS1) regulated during HP-PRRSV infection (Fig-
ure 3).  
Cytoskeleton and exocytosis organization in 
PAMs 
Nine  genes  (S100A6,  MARCKS,  CACYBP, 
CCT6A, ARHE, CCT3, PTPN4, CCT7, and TWF1) re-
lated to actin and tubulin cytoskeleton organization 
were  upregulated  and  three  (RASSF8,  ELMO1,  and 
KIF11)  were  downregulated  (Table  3).  In  addition, 
several  exocytosis  related  genes  (RSAD2,  GSK3B, 
LMAN2L,  EXOC2,  SELS,  COPZ2,  SEC31L2,  and 
SEC8L1) were differentially expressed in PAMs after 
HP-PRRSV infection (Table 3).  RSAD2, encoding an 
IFN-induced protein which inhibits influenza A virus 
release from the plasma membrane of infected cells by 
affecting the formation of lipid rafts [28], was upreg-
ulated  significantly.  Vesicle  trafficking  between  the 
Golgi apparatus and ER seemed to be restricted, be-
cause COPZ2, a member of the COPI coat which helps 
vesicles  transport  proteins  from  the  cis  end  of  the 
Golgi  complex  back  to  the  rough  ER  [29],  and 
SEC31L2, a component of the COPII vesicle coat that 
mediates vesicular traffic from the rough  ER to the 
Golgi apparatus [30], were both downregulated.  
 
 
Figure 3 Sensing the HP-PRRSV infection by host cell. PRRSV enters early endosomes but does not continue through the 
endocytic pathway to late endosomes [48]. The ATP6V1B2 gene, which encodes a component of vacuolar ATPase (V-ATPase) 
that mediates acidification of endosomal organelles [23], facilitates the uncoating of the virus. Viral nucleic acids could be 
sensed by Toll-like receptors (TLRs) pathway or RIG-I pathway both of which lead to type-I IFN induction by activating IRF3 
and IRF7, and to inflammatory cytokines expression by activating the MAPK signaling pathway. Several IFN-induced genes 
were upregulated during HP-PRRSV infection, even though no induction of type-I IFN was observed. Red background in the 
gene box indicates upregulation of the gene expression, green indicates downregulation, and white indicates no change of 
the gene expression. Fold changes of the differentially expressed genes are 1.94 (ATP6V1B2), 0.31 (SARM1), 4.58 (IRF7), 




Table 2 Interferon induced genes 
Gene symbol  Gene description  Affymetrix probe set ID  Fold Change 
GBP1  guanylate binding protein 1, interferon-inducible, 67kDa  Ssc.29054.1.A1_at  3.51 
GBP2  guanylate binding protein 2, interferon-inducible  Ssc.883.1.S1_a_at  4.32 
GZMB  granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)  Ssc.4939.2.S1_at  19.07 
GZMH  granzyme H (cathepsin G-like 2, protein h-CCPX)  Ssc.25976.1.S1_at  4.75 
IFI16  interferon, gamma-inducible protein 16  Ssc.10884.1.A1_at  3.41 
IFI6  Interferon, alpha-inducible protein 6  Ssc.20101.1.S1_at  4.34 
IFIH1  interferon induced with helicase C domain 1  Ssc.17894.1.A1_at  3.53 
IFIT2  interferon-induced protein with tetratricopeptide repeats 2  Ssc.22620.1.S1_at  6.16 
IFIT3  interferon-induced protein with tetratricopeptide repeats 3  Ssc.31140.1.S1_at  4.17 
IFITM3  interferon induced transmembrane protein 3 (1-8U)  Ssc.30956.1.A1_s_at  6.05 
ISG15  ISG15 ubiquitin-like modifier  Ssc.11557.1.A1_at  7.89 
MX1  myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse)  Ssc.221.1.S1_at  4.45 
NMI  N-myc (and STAT) interactor  Ssc.9572.1.A1_at  1.81 
RSAD2  radical S-adenosyl methionine domain containing 2  Ssc.286.1.S1_s_at  9.74 
USP18  ubiquitin specific peptidase 18  Ssc.336.1.S1_at  3.1 
 
Table 3 DE genes and their relation to different aspects of the host cell organization 
Gene symbol  Gene description  Affymetrix probe set ID  Fold Change 
Cytoskeleton 
S100A6  S100 calcium binding protein A6  Ssc.21109.1.S1_a_at  4.87  
MARCKS  MARCKS-like 1  Ssc.1228.1.S1_at  3.00  
CACYBP  calcyclin binding protein   Ssc.10299.1.A1_at  2.28  
CCT6A  chaperonin containing TCP1, subunit 6A (zeta 1)  Ssc.11348.1.A2_at  2.06  
ARHE  Rho family GTPase 3  Ssc.4127.2.A1_at  1.87  
CCT3  chaperonin containing TCP1, subunit 3 (gamma  Ssc.902.1.S1_a_at  1.71  
PTPN4  protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte)  Ssc.29697.1.A1_at  1.70  
CCT7  chaperonin containing TCP1, subunit 7 (gamma  Ssc.11002.1.S1_at  1.64  
TWF1  twinfilin, actin-binding protein, homolog 1 (Drosophila)  Ssc.7177.1.A1_at  1.57  
RASSF8  Ras association (RalGDS/AF-6) domain family (N-terminal) member   Ssc.15288.1.S1_at  0.64  
ELMO1  engulfment and cell motility 1  Ssc.5648.1.A1_at  0.63  
KIF11  kinesin family member 11  Ssc.30748.1.S1_at  0.40  
Exocytosis and vesicle trafficking 
RSAD2  radical S-adenosyl methionine domain containing 2  Ssc.286.1.S1_s_at  9.74  
GSK3B  glycogen synthase kinase 3 beta  Ssc.30917.1.A1_at  3.09  
LMAN2L  lectin, mannose-binding 2-like  Ssc.24211.1.S1_at  1.71  
EXOC2  exocyst complex component 2  Ssc.7976.1.A1_at  1.71  
SELS  selenoprotein S  Ssc.2739.1.S1_at  1.71  
COPZ2  coatomer protein complex, subunit zeta 2  Ssc.4221.1.S1_at  0.49  
SEC31L2  SEC31 homolog B (S. cerevisiae)  Ssc.31182.1.A1_at  0.43  
SEC8L1  exocyst complex component 4  Ssc.9822.1.A1_at  0.25  
Ubiquitination and ISGylation 
ISG15  ISG15 ubiquitin-like modifier  Ssc.11557.1.A1_at  7.89  
USP18  ubiquitin specific peptidase 18  Ssc.336.1.S1_at  3.10  
CACYBP  calcyclin binding protein   Ssc.10299.1.A1_at  2.28  
HERPUD1  homocysteine-inducible, endoplasmic reticulum stress-inducible, 
ubiquitin-like domain member 1 
Ssc.12017.1.A1_at  2.06  
CUL1  cullin 1  Ssc.30295.1.A1_at  1.60  
HERC6  hect domain and RLD 6  Ssc.26483.1.A1_at  1.66  
HERC3  hect domain and RLD 3  Ssc.9737.1.S1_at  0.39  




UBASH3B  ubiquitin associated and SH3 domain containing B  Ssc.25139.3.S1_at  0.35  
Chaperones 
NPM3  nucleophosmin/nucleoplasmin 3  Ssc.6196.1.S1_at  2.23  
CCT3  chaperonin containing TCP1, subunit 3 (gamma  Ssc.902.1.S1_a_at  1.71  
CCT7  chaperonin containing TCP1, subunit 7 (gamma  Ssc.11002.1.S1_at  1.64  
CCT6A  chaperonin containing TCP1, subunit 6A (zeta 1)  Ssc.11348.1.A2_at  2.06  
DNAJA1  DnaJ (Hsp40) homolog, subfamily A, member 1  Ssc.8473.1.S2_at  2.03  
DNAJA4  DnaJ (Hsp40) homolog, subfamily A, member 4  Ssc.17243.1.S1_at  11.31  
DNAJB1  DnaJ (Hsp40) homolog, subfamily B, member 1  Ssc.3502.1.S1_at  3.46  
DNAJB2  DnaJ (Hsp40) homolog, subfamily B, member 2  Ssc.1180.1.S1_at  1.54  
DNAJB4  DnaJ (Hsp40) homolog, subfamily B, member 4  Ssc.13345.1.A1_at  8.78  
HSPA1B  heat shock 70kDa protein 1A  Ssc.5145.1.S1_at  4.44  
HSPA4  Heat shock 70kDa protein 4  Ssc.3313.1.S1_at  2.46  
HSPA4  heat shock 70kDa protein 4  Ssc.11197.1.S1_at  1.98  
HSPA6  heat shock 70kDa protein 6 (HSP70B')  Ssc.6728.1.S1_at  1.60  
HSPD1  heat shock 60kDa protein 1 (chaperonin)  Ssc.6719.1.A1_at  1.83  
HSPH1  heat shock 105kDa/110kDa protein 1  Ssc.1231.1.A1_at  2.94  
Intracellular calcium homeostasis 
CKM  creatine kinase, muscle  Ssc.415.1.S1_at  9.13  
KLB  klotho beta  Ssc.7252.1.A1_at  2.77  
HERPUD1  homocysteine-inducible, endoplasmic reticulum stress-inducible, 
ubiquitin-like domain member 1 
Ssc.12017.1.A1_at  2.06  
TRPM4  transient receptor potential cation channel, subfamily M, member 4  Ssc.10022.1.A1_at  1.81  
HAX1  HCLS1 associated protein X-1   Ssc.6188.1.S1_at  1.79  
PIK3C2A  phosphoinositide-3-kinase, class 2, alpha polypeptide  Ssc.29061.1.A1_at  0.58  
PIK3R2  phosphoinositide-3-kinase, regulatory subunit 2 (beta)  Ssc.1677.1.A1_at  0.47  
Zinc ion signaling 
SLC39A14  solute carrier family 39 (zinc transporter), member 14  Ssc.19143.1.A1_at  5.06  
ZDHHC9  zinc finger, DHHC-type containing 9   Ssc.16227.1.S1_at  16.57  
ZFAND2A  zinc finger, AN1-type domain 2A   Ssc.5082.1.A1_at  2.75  
ZCCHC6  zinc finger, CCHC domain containing 6  Ssc.21294.1.S1_at  2.21  
ZCWPW1  zinc finger, CW type with PWWP domain 1  Ssc.31003.1.A1_at  2.04  
ZFP2  ZFP2 zinc finger protein 2 homolog  Ssc.7514.1.A1_at  1.84  
ZNF258  zinc finger, MYM-type 6  Ssc.17765.1.S1_at  0.50  
 
Protein degradation and folding in PAMs 
During  HP-PRRSV  infection,  homeostasis  of 
ISGylation, an ubiquitin-like modification, seemed to 
be re-established in PAMs by enhancing the expres-
sion of ISG15, an ubiquitin-like protein, and USP18, 
which is an ISG15 deconjugating protease (Table 3). 
Three  E3  ubiquitin  ligase  genes  (CACYBP,  HERC6, 
CUL1)  were  upregulated,  and  two  (HERC3,  G2E3) 
were downregulated (Table 3). As expected, a large 
set of chaperone genes were upregulated, including 
heat  shock  40  kDa  protein  (Hsp40)  (DNAJA1, 
DNAJA4,  DNAJB1,  DNAJB2,  and  DNAJB4),  Hsp60 
(HSPD1),  Hsp70  (HSPA1B,  HSPA4,  HSPA4,  and 
HSPA6),  Hsp105/110  (HSPH1),  and  subunits  of 
chaperon  in  containing  t-complex  polypeptide  1 
(CCT3, CCT7, and CCT6A), as well as NPM3, a mo-
lecular chaperone in the cell nucleus (Table 3). 
Intracellular calcium and zinc homeostasis in 
PAMs 
Upon  HP-PRRSV  infection,  several  DE  genes 
were involved in the intracellular calcium homeosta-
sis in PAMs (Table 3). After HP-PRRSV infection, zinc 
ion concentration in PAMs seemed to be increased, 
through  upregulating  the  expression  of  SLC39A14 
which encodes a zinc influx transporter [31] (Table 3). 
Several zinc finger protein encoding genes (ZDHHC9, 
ZFAND2A, ZCCHC6, ZCWPW1, ZFP2, ZNF258) were 
also identified as DE genes, and all of them were up-
regulated, except ZNF258 (Table 3). 
Tissue remolding and inflammation 
During HP-PRRSV infection, a set of DE genes 
involved in the dynamic regulation of the extracellu-
lar matrix and vascular permeability was identified 




alveoli, as a sign of inflammation, was modulated by 
upregulating a small number of genes (CCL2, CCL4L, 
CCR5 and CSF1) (Table 4). Three genes, MPP1, PF4, 
and PPBP involved in neutrophil infiltration or acti-
vation  [32-34],  were  all  downregulated  (Table  4). 
During HP-PRRSV infection, complement activation 
seemed to be inhibited, as expression of C3 and PFC, a 
positive  regulator  of  complement  activation,  were 
downregulated, and CLU, encoding for a complement 
inhibitor, was upregulated (Table 4). 
Confirmation of differential expression by Q-PCR 
Seven  genes  (CCL2,  SLC39A14,  ATP6V1B2,  C3, 
DDIT3,  GLRX2  and  TNF)  were  selected  for  Q-PCR 
assay to validate the changes in gene expression ob-
served  by  microarray  analysis.  CCL2  was  the  main 
upregulated chemokine gene in this study (Table 4). 
Two  upregulated  genes,  SLC39A14  and  ATP6V1B2, 
were involved in intracellular zinc homeostasis and 
endosome acidification, respectively. The downregu-
lated C3 gene is the core member of the complement 
system  which  seemed  to  be  inhibited,  according  to 
our  study  (Table  4).  The  Q-PCR  gene  list  also  con-
tained two DE genes (DDIT3, GLRX2) which were not 
referred to in the discussion, and TNF, an important 
cytokine gene, which was not differentially expressed 
in Tongcheng PAMs in response to HP-PRRSV infec-
tion. The changes of these genes, detected by micro-
array  analysis,  was  in  agreement  with  the  Q-PCR 
validation (Figure 4). 
 
Table 4 DE genes and their relation to tissue remolding and inflammation 
Gene symbol  Gene description  Affymetrix probe set ID  Fold Change 
Extracellular matrix homeostasis 
TIMP1  TIMP metallopeptidase inhibitor 1  Ssc.11784.1.S1_at  4.48  
PLOD1  procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1  Ssc.3530.1.A1_at  3.74  
CSPG2  versican  Ssc.5663.1.S1_at  3.19  
ADAMTSL3  ADAMTS-like 3  Ssc.11976.1.A1_at  2.72  
LAMC1  laminin, gamma 1 (formerly LAMB2)   Ssc.1099.1.S1_at  2.46  
ADAMTS20  ADAM metallopeptidase with thrombospondin type 1 motif, 20  Ssc.29491.1.A1_at  2.40  
ST14  suppression of tumorigenicity 14 (colon carcinoma)  Ssc.3285.1.S1_at  1.84  
MMP28  matrix metallopeptidase 28  Ssc.29059.1.A1_at  0.53  
NDST4  N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4  Ssc.13434.2.A1_at  0.49  
TGFBI  transforming growth factor, beta-induced, 68kDa  Ssc.16671.1.S1_at  0.36  
Vascular permeability 
LRP11  low density lipoprotein receptor-related protein 11  Ssc.14282.1.A1_at  4.37  
LRP8  low density lipoprotein receptor-related protein 8, apolipoprotein e receptor  Ssc.31016.1.A1_at  3.29  
SELL  selectin L  Ssc.22075.3.A1_at  2.97  
SCPEP1  serine carboxypeptidase 1  Ssc.3037.3.A1_at  2.21  
ANGPTL4  angiopoietin-like 4  Ssc.8980.1.A1_at  0.51  
PLVAP  plasmalemma vesicle associated protein  Ssc.3645.1.S1_at  0.19  
Complement system 
CLU  clusterin  Ssc.11992.1.A1_at  14.52  
PFC  complement factor properdin  Ssc.27474.1.S1_at  0.49  
C3  complement component 3  Ssc.61.1.S1_at  0.29  
Immune cells recruitment and activation 
CCL2  chemokine (C-C motif) ligand 2  Ssc.657.1.A1_at  14.17  
CSF1  colony stimulating factor 1 (macrophage)  Ssc.6369.1.A1_at  6.71  
CCL4L  chemokine (C-C motif) ligand 4-like 1  Ssc.23797.1.S1_at  4.86  
CLECL1  C-type lectin-like 1  Ssc.12825.1.A1_at  2.66  
IL1RAP  interleukin 1 receptor accessory protein  Ssc.7864.1.A1_at  2.49  
CCR5  chemokine (C-C motif) receptor 5  Ssc.26328.1.S1_at  2.20  
MPP1  membrane protein, palmitoylated 1, 55kDa  Ssc.19356.1.S1_at  0.57  
PPBP  pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)  Ssc.16228.1.S1_at  0.39  
PF4  platelet factor 4 (chemokine (C-X-C motif) ligand 4)  Ssc.24188.1.A1_at  0.35  
  





Figure 4 Q-PCR validation of the microarray data. P val-
ues  (T-test)  of  the  Q-PCR  data  are  0.018  (CCL2),  0.039 
(SLC39A14),  0.044  (DDIT3),  0.006  (GLRX2),  0.008 
(ATP6V1B2), 0.508 (TNF) and 0.032 (C3), respectively. TNF 
is a non-differentially expressed gene. 
 
Discussion 
The results of this study showed that Tongcheng 
piglets exhibited typical clinical signs following infec-
tion with HP-PRRSV WUH3 strain. The lung damage 
caused by the infection was regional and mild at 5 and 
7 dpi (Figure 1C and D), but further observation for a 
longer period of time was not performed in this study. 
The slow reproduction rate of the virus (viremia) at 3 
to 7 dpi (Figure 1B) suggested a near balance between 
the viral replication and the defense mechanisms in 
the PAMs. Transcriptomic analysis of the PAMs at 5 
dpi identified 321 DE genes under the filter of 1.5-fold 
change, and the number of upregulated genes (219) 
was greater than that of downregulated genes (102). 
In comparison, an in vitro transcriptomic analysis of 
PAMs  revealed  that  only  small  numbers  (no  more 
than 100) of DE genes (threshold of 1.5-fold change) 
were identified at 1 to 12 hours post PRRSV infection, 
and the overall effect of PRRSV on the host transcrip-
tion machinery was downegulation [8]. It is not sure 
whether there is a conversion of the overall effect of 
PRRSV on host transcription machinery from down-
regulation  to  upregulaton  as  time  goes  on,  or  the 
change is only the effect of the difference between in 
vitro and in vivo assays. As compared with the number 
of  DE  genes  in  this  study,  some  thousands  of  DE 
genes  (threshold  of  almost  1.5-fold  change)  were 
identified in lung tissues at 4 and 7 dpi following both 
PRRSV and HP-PRRSV infection, by high-throughput 
deep sequencing assays [6, 7]. This great number of 
DE genes might result from the huge amount of data 
obtained  by  the  deep-sequencing  method  and  from 
the many cell types in lung tissues. 
PRRSV is considered to inhibit the synthesis of 
type-I  IFNs  and  its  signaling  by  blocking 
STAT1/STAT2 nuclear translocation [35]. However, it 
is  also  reported  that  PRRSV  can  phosphorylate 
IFN-regulatory  factor  3  (IRF-3)  and  weakly  activate 
the IFN-β promoter in MARC-145 cells in early infec-
tion, but the activations of IRF-3 and IFN-β promoter 
are rapidly inhibited in the following infection [36]. 
The induction of IFN-β mRNA, but not IFN-α mRNA, 
is observed in monocyte-derived dendritic cells and 
primary alveolar macrophages infected by PRRSV at 
12 dpi [8, 37]. In some cases, even the expression of 
IFN-α can be detected in the lung [38] or serum [39] of 
pigs infected with PRRSV during the early days. In-
terestingly, in this study, no induction of type-I IFN 
was detected in PAMs at 5 dpi (Figure 3), whereas a 
series of IFN induced genes that are critical for the cell 
to defend itself against viral infection, were upregu-
lated  (Table  2).  Similar  results  were  shown  in  lung 
tissues  at  4  and  7  dpi  following  both  PRRSV  and 
HP-PRRSV infection [6, 7], and it was speculated that 
the IFN induced genes were predominantly expressed 
by the uninfected cells [7]. Here, another possibility is 
suggested that a certain amount of type-I IFN might 
be induced at the early stage of the infection before 5 
dpi. 
During HP-PRRSV infection, several aspects of 
the PAMs’ function  were under regulation, such as 
actin and tubulin cytoskeleton organization, exocyto-
sis, protein degradation, protein folding, intracellular 
calcium and zinc homeostasis (Table 3). Increasing of 
intracellular zinc concentration impairs the replication 
of  a  variety  of  RNA  viruses,  including  poliovirus, 
influenza  virus,  coronavirus,  arterivirus,  rhinovirus, 
and respiratory syncytial virus [40-42]. Recently, zinc 
ion  has  been  reported  to  efficiently  inhibit  the 
RNA-synthesizing activity of the multiprotein repli-
cation  and  transcription  complex  of  both 
SARS-coronavirus  and  equine  arteritis  virus  [40]. 
Upregulation  of  SLC39A14  (also  known  as  Zip14) 
(Table 3), a member of the SLC39 (Zip) family which 
transports zinc from the extracellular space or orga-
nellar lumen into the cytoplasm [43], might be a de-
fense mechanism in PAMs during HP-PRRSV infec-
tion.  Nevertheless,  none  of  the  SLC39  family  genes 
was identified as a DE gene in a microarray assay of 
PAMs infected with PRRSV in vitro [8]. Furthermore, 




SLC39  family,  was  downregulated  in  the  lungs  of 
Landrace×Yorkshire  crossbred  piglets  at  7  dpi  fol-
lowing HP-PRRSV infection [7]. 
It has been shown in this study, that modulated 
inflammatory reaction, with a few proinflammatory 
cytokines upregulated (CCL2, CCL4L and its receptor 
CCR5, and CSF1) (Table 4), might contribute  to the 
mild  regional  lung  lesion  observed  at  5  and  7  dpi 
(Figure 1C and D). Besides, the complement system is 
one of the key players in the defense against infec-
tions.  However,  excessive  activation  of  the  comple-
ment can also exaggerate the disease induced by viral 
or bacterial infection. In 2009, a new H1N1 influenza 
A virus caused severe disease in naive middle-aged 
human  individuals  with  preexisting  immunity 
against seasonal strains, and this disease is reported to 
be  induced  through  high  titers  of  low-avidity  non-
protective antibody and immune complex-mediated 
complement  activation  in  the  respiratory  tract  [44]. 
Excessive  complement  activation  can  contribute  to 
organ damage in combination with the cytokine storm 
in the later stages of sepsis caused by bacterial infec-
tion [45]. It is reported that blocking complement ac-
tivation  can  ameliorate  hepatic  inflammation  medi-
ated by the hepatitis C virus core protein [46]. Like-
wise, inhibition of complement with a potent C3 in-
hibitor (compstatin) in a baboon model of late-stage 
sepsis  markedly  improves  organ  preservation  and 
other clinical parameters [47]. As it has been shown 
here, inhibition of the complement system might also 
be  a  contributor  to  the  mild  regional  lung  damage 
during HP-PRRSV infection. Interestingly, infection of 
HP-PRRSV  in  six-week-old  crossbred  weaned  pigs 
(Landrace  ×  Yorkshire)  induces  complement  activa-
tion accompanied by severe lung damage [7].  
Conclusions 
In  summary,  the  data  presented  in  this  study 
suggested  that  during  infection  with  HP-PRRSV 
Tongcheng piglets exhibited typical clinical signs, but 
displayed mild regional lung damage at 5 and 7 dpi. 
Microarray  analysis  revealed  that  HP-PRRSV  infec-
tion  has affected PAMs in vivo in expression  of the 
important genes involved in cytoskeleton and exocy-
tosis organization, protein degradation and folding, 
intracellular  calcium  and  zinc  homeostasis.  Several 
potential  antiviral  strategies  might  be  employed  in 
PAMs,  including  upregulating  IFN-induced  genes 
and  increasing  intracellular  zinc  ion  concentration. 
Furthermore,  inhibition  of  the  complement  system 
likely attenuated the lung damage during HP-PRRSV 
infection. This system analysis could lead to a better 
understanding of the HP-PRRSV-host interaction, and 
to the identification of novel antiviral therapies and 
identifying  genetic  components  for  swine  toler-
ance/susceptibility to HP-PRRS. 
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